Exchange: OTC·Updated 02:43 PM EST

ACUT Accustem Sciences Inc

$0.118
$0.00
(0.00%)
Today
Mkt Cap$1.9M
Vol2.00

About ACUT

AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
66

Bullish Sentiment

How do you feel about ACUT?

Advertisement|Remove ads.